Verrica Pharmaceuticals Inc.

$VRCA is up about 50% at the time of posting due to news that its partner, Torii Pharmaceutical, reported positive results from its Phase 3 trial of its treatment for molluscum contagiosum

Share This Article

 

About the Author

Verrica Pharmaceuticals Inc.

Joey Ramson